{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:05:38Z","timestamp":1770440738038,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fund for Scientific Research in Flanders"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejps.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T11:30:32Z","timestamp":1406028632000},"page":"178-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability"],"prefix":"10.1016","volume":"63","author":[{"given":"Jef","family":"Stappaerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Wuyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.07.009_b0005","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/mp300164u","article-title":"Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems","volume":"9","author":"Anby","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b9000","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/mp100377m","article-title":"Excipient-mediated supersaturation stabilization in human intestinal fluids","volume":"8","author":"Bevernage","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0010","doi-asserted-by":"crossref","unstructured":"Clarysse, S., Psachoulias, D., Brouwers, J., Tack, J., Annaert, P., Duchateau, G., Reppas, C., Augustijns, P., 2009a. Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. 1456\u20131466.","DOI":"10.1007\/s11095-009-9857-7"},{"key":"10.1016\/j.ejps.2014.07.009_b0015","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.21502","article-title":"Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states","volume":"98","author":"Clarysse","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0020","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/mp100175a","article-title":"High-permeability criterion for BCS classification: segmental\/pH dependent permeability considerations","volume":"7","author":"Dahan","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0025","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/mp100049m","article-title":"Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media","volume":"7","author":"Fagerberg","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0030","first-page":"416","article-title":"Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers","volume":"79","author":"Fischer","year":"2011","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft F\u00fcr Pharm. Verfahrenstechnik EV"},{"key":"10.1016\/j.ejps.2014.07.009_b0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.2042-7158.2011.01301.x","article-title":"In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants","volume":"63","author":"Fischer","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpharm.2012.08.014","article-title":"Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement","volume":"437","author":"Frank","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0045","first-page":"16","article-title":"Impact of FaSSIF on the solubility and dissolution-\/permeation rate of a poorly water-soluble compound","volume":"47","author":"Frank","year":"2012","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0050","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jps.23979","article-title":"What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?","volume":"103","author":"Frank","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bdd.751","article-title":"Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue","volume":"32","author":"Haslam","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2014.07.009_b0060","first-page":"27","article-title":"Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine","volume":"49","author":"Holmstock","year":"2013","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0065","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/mp300410n","article-title":"Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification","volume":"10","author":"Incecayir","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0075","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0006-2952(99)00262-2","article-title":"Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity","volume":"58","author":"Jonsson","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0080","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/jps.20687","article-title":"Permeability assessment of poorly water-soluble compounds under solubilizing conditions: the reciprocal permeability approach","volume":"95","author":"Katneni","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0085","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.2042-7158.2010.01023.x","article-title":"Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies","volume":"62","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0090","doi-asserted-by":"crossref","unstructured":"Kloefer, B., van Hoogevest, P., Moloney, R., Kuentz, M., Leigh, M.L.S., Dressman, J., 2010. Study of a standardized taurocholate\u2013lecithin powder for preparing the biorelevant media FeSSIF and FaSSIF. diss.","DOI":"10.14227\/DT170310P6"},{"issue":"Suppl 11","key":"10.1016\/j.ejps.2014.07.009_b0095","article-title":"A pharmacokinetic study of carvedilol (BM 14.190) in elderly subjects: preliminary report","volume":"10","author":"Louis","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0100","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/gut.24.8.734","article-title":"Determination of acid surface pH in vivo in rat proximal jejunum","volume":"24","author":"Lucas","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2014.07.009_b0105","article-title":"Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness","author":"Markopoulos","year":"2013","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV."},{"key":"10.1016\/j.ejps.2014.07.009_b0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00605630","article-title":"Food-induced reduction in bioavailability of atenolol","volume":"16","author":"Melander","year":"1979","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0120","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp200181v","article-title":"The solubility\u2013permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","volume":"8","author":"Miller","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0115","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/mp300104s","article-title":"A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability","volume":"9","author":"Miller","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4103\/0250-474X.99000","article-title":"Development and validation of new discriminative dissolution method for carvedilol tablets","volume":"73","author":"Murthy","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0130","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1211\/jpp.58.8.0009","article-title":"Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum","volume":"58","author":"Perez de la Cruz Moreno","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jps.10005","article-title":"Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution","volume":"91","author":"Poulin","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2003.08.006","article-title":"PAMPA\u2014a drug absorption in vitro model: 5. Unstirred water layer in iso-pH mapping assays and pKa flux\u2014optimized design (pOD-PAMPA)","volume":"20","author":"Ruell","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ddr.20008","article-title":"A quantitative approach to probe the dependence and correlation of food-effect with aqueous solubility, dose\/solubility ratio, and partition coefficient (Log P) for orally active drugs administered as immediate-release formulations","volume":"65","author":"Singh","year":"2005","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejps.2014.07.009_b0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption \u2013 comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sj\u00f6gren","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/jps.23892","article-title":"Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations","volume":"103","author":"Stillhart","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2125.1981.tb01264.x","article-title":"Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists","volume":"12","author":"Taylor","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.009_b0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02713689109001766","article-title":"Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration","volume":"10","author":"Wang","year":"1991","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2014.07.009_b0170","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1002\/jps.23698","article-title":"Solubility profiling of HIV protease inhibitors in human intestinal fluids","volume":"102","author":"Wuyts","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0175","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/jps.21919","article-title":"Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes","volume":"99","author":"Yano","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.009_b0180","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s11095-013-1104-6","article-title":"Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles","volume":"30","author":"Yeap","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.07.009_b0185","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1021\/mp400035z","article-title":"The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs","volume":"10","author":"Yeap","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.07.009_b0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpba.2014.03.019","article-title":"Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid","volume":"96","author":"Yuvaraja","year":"2014","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T22:37:55Z","timestamp":1565649475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714003054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":39,"alternative-id":["S0928098714003054"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.07.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}